Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey.
Mollie A MonnigHayley Treloar PadovanoAlexander W SokolovskyGrace DeCostElizabeth R AstonCarolina L Haass-KofflerClaire SzaparyPatience MoyoJaqueline C AvilaJennifer W TideyPeter M MontiJasjit S AhluwaliaPublished in: JMIR public health and surveillance (2021)
In a regionally-specific, racially, and ethnically diverse convenience sample, adults who engaged in daily alcohol or opioid use reported lower CDC guideline adherence for COVID-19 mitigation. Any opioid use was associated with greater odds of COVID-19 testing, and daily stimulant use was associated with greater odds of COVID-19 infection. Cigarettes, electronic cigarettes, cannabis, or stimulant use were not statistically associated with CDC guideline adherence, after accounting for sociodemographic covariates and other substance use variables. Findings support further investigation into whether COVID-19 testing and vaccination should be expanded among individuals with substance-related risk factors.